复星作为一种潜在的保护性化合物,可以抵抗骨肌肉对胰岛素的抵抗
Arash Bahramzadeh1, Kosar Bolandnazar2, Reza Meshkani1
1Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Heliyon
|November 29, 2023
概括
复星是一种植物聚醇,通过改善骨肌肉中的胰岛素抵抗力来对抗2型糖尿病. 本综述总结了关于其机制和治疗潜力的证据.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 营养生物化学 营养生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病是一个日益严重的全球健康问题,主要是由胰岛素抵抗驱动的.
- 骨肌肉在葡萄糖调节中起着至关重要的作用,使其成为胰岛素抵抗的关键部位.
- 现有的糖尿病治疗有局限性,需要新的治疗方法.
研究的目的:
- 审查复星在解决骨肌肉中的胰岛素抵抗方面的作用.
- 总结一下白醇抗糖尿病作用的基本机制.
- 巩固研究各种研究模型的研究结果,研究复星和胰岛素耐药性.
主要方法:
- 在PubMed,Scopus和Web of Science数据库中的系统文献搜索.
- 包括细胞培养,动物和人类研究.
- 对调查复星对骨肌肉胰岛素耐药性的影响的研究分析.
主要成果:
- 在不同模型中,白醇对骨肌肉中的胰岛素抵抗产生有益影响.
- 有证据表明,复星可以通过多种机制改善葡萄糖平衡.
- 该化合物显示出作为2型糖尿病辅助治疗的潜力.
结论:
- 复星作为一种有前途的天然化合物来治疗2型糖尿病,特别是关于骨肌肉的胰岛素耐药性.
- 进一步研究复星的治疗应用是有必要的.
- 像白醇这样的植物性化合物为新的糖尿病治疗提供了潜在的途径.
更多相关视频
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
8.8K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.7K
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
209
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
209
